Nido Biosciences

Nido Bio is translating todays neuroscience breakthroughs into tomorrows treatments for severe neurological diseases. Leveraging human genetics, we develop precision medicines that address the fundamental biology of disease and restore healthy cell function. NIDO-361, our clinical-stage candidate, is a treatment for Spinal and Bulbar Muscular Atrophy which is a rare and debilitating neuromuscular disease. Additional pipeline programs center around a novel target with the potential to address multiple disease mechanisms and that has broad clinical application across neurodegenerative and peripheral inflammatory diseases. We are creating a sustainable pipeline for the company by utilizing a functional genomics discovery platform based on...

Nido biosciences operates in the Biotechnology research industry.

Nido biosciences's revenue is 11m - 100m

Nido biosciences has 11 - 50 employees.